TRIALCHAT: Developing Agentic AI Chatbot Tools with Older Adults and Caregivers to Encourage Participation in ADRD Clinical Trials

The Massachusetts AI and Technology Center for Connect Care in Aging & Alzheimer's Disease (MassAITC) is hosting a webinar to discuss “TRIALCHAT", a multiagentic AI tool developed by S-3 Research and California State Fullerton to help older adults and their caregivers access resources related to Alzheimer’s Disease and clinical research participation opportunities.

S-3 Research CEO and Co-founder Tim Ken Mackey will also be a featured speaker. Click here for more information.